Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

FDA Warns of Paralyzing Poison Danger From Pacific Northwest Shellfish

Seafood lovers should steer clear of shellfish from Oregon and Washington state because of possible contamination with a paralyzing toxin, the U.S. Food and Dru

Many Louisiana Residents May Be Exposed to Sky-High Levels of Toxic Gas

Many Louisiana residents are being exposed to a cancer-causing toxic gas that s used in industrial settings, researchers report. A cutting-edge mobile air-testi

FDA Advisors Support New Alzheimer's Drug

A U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer s outweigh its harms,

First Patient Enrolled in Global Phase 3 Clinical Program for Elamipretide in Patients with Dry Age-Related Macular Degeneration

NEEDHAM, Mass., June 05, 2024. Stealth BioTherapeutics Inc. (the Company or Stealth ), a clinical-stage biopharmaceutical company focused on the discovery, deve

Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA

Gilead Sciences, Inc. (Nasdaq GILD) today announced data from the Phase 2b MYR204 open-label study assessing the efficacy and safety of the first-in-class entry

AbbVie Announces Positive Topline Results from Phase 2 Trial Evaluating Elahere for High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer

NORTH CHICAGO, Ill., June 6, 2024. AbbVie announced today positive topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab soravt

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials

DURHAM, N.C. and BEIJING, June 7, 2024. Brii Biosciences Limited ( Brii Bio, we, or the Company ), a biotechnology company developing therapies to improve patie

Alzheimer's drug discovery foundation's statement on FDA advisory committee's endorsement of donanemab

NEW YORK, June 10, 2024. Today, the FDA Peripheral and Central Nervous System Drugs Advisory Committee unanimously voted that donanemab shows clinical benefit f

Supernus Provides Regulatory Update for SPN-830

Abeona Therapeutics Provides Regulatory Update on Pz-cel

Popular Keywords